X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RLYB

Closed

Rallybio Corp

0.3303
-0.0077 (-2.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.338
Day's Range: 0.327 - 0.34
Send
When Written:
 
5.01
Rallybio Corp is a biotechnology company that focuses on developing therapies for rare diseases. The company was founded in 2018 and is based in Farmington, Connecticut. Rallybio's mission is to identify and develop transformative therapies for patients with severe and debilitating diseases that currently have limited treatment options. The company's pipeline includes potential treatments for rare diseases such as infantile malignant osteopetrosis, Alagille syndrome, and pyruvate kinase deficiency. In 2020, Rallybio raised $145 million in a Series B funding round to advance its pipeline and expand its team.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X